14th Annual Meeting of the Safety Pharmacology Society: threading through scientific sessions for originality and novelty

Bibliography

• Brell JM. Animal models of peripheral neuropathy: modeling what we feel, understanding what they feel. ILAR J 2014;54:253-8
   PubMed Web of Science ®Google Scholar
• Han Y, Smith MT. Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN). Front Pharmacol 2013;4:156
   PubMed Web of Science ®Google Scholar
• Podratz JL, Knight AM, Ta LE, et al. Cisplatin induced mitochondrial DNA damage in dorsal root ganglion neurons. Neurobiol Dis 2011;41:661-8
   PubMed Web of Science ®Google Scholar
• Ta LE, Espeset L, Podratz J, Windebank AJ. Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding. Neurotoxicology 2006;27:992-1002
   PubMed Web of Science ®Google Scholar
• Cavaletti G, Marmiroli P. Chemotherapy-induced peripheral neurotoxicity. Nat Rev Neurol 2010;6:657-66
   PubMed Web of Science ®Google Scholar
• Bird SJ, Brown M J, Spino C, et al. Value of repeated measures of nerve conduction and quantitative sensory testing in a diabetic neuropathy trial. Muscle Nerve 2006;34:214-24
   PubMed Web of Science ®Google Scholar
• Hausheer FH, Schilsky RL, Bain S, et al. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy. Semin Oncol 2006;33:15-49
   PubMed Web of Science ®Google Scholar
• Höke A, Ray M. Rodent models of chemotherapy-induced peripheral neuropathy. ILAR J 2014;54:273-81
   PubMed Web of Science ®Google Scholar
• Yalcin I, Megat S, Barthas F, et al. The sciatic nerve cuffing model of neuropathic pain in mice. J Vis Exp 2014;89
   PubMedGoogle Scholar
• Chaplan SR, Bach FW, Pogrel JW, et al. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994;53:55-63
   PubMed Web of Science ®Google Scholar
• Bonin RP, Bories C, De Koninck Y. A simplified up-down method (SUDO) for measuring mechanical nociception in rodents using von Frey filaments. Mol Pain 2014;10:26
   PubMed Web of Science ®Google Scholar
• Podratz JL, Knight AM, Ta LE, et al. Cisplatin induced mitochondrial DNA damage in dorsal root ganglion neurons. Neurobiol Dis 2011;41:661-8
   PubMed Web of Science ®Google Scholar
• Ta LE, Espeset L, Podratz J, et al. Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglia- on neurons correlates with platinum-DNA binding. Neurotoxicology 2006;27:992-1002
   PubMed Web of Science ®Google Scholar
• Wozniak KM, Nomoto K, Lapidus RG, et al. Comparison of neuropathy-inducing effects of eribulin mesylate, paclitaxel, and ixabepilone in mice. Cancer Res 2011;71:3952-62
   PubMed Web of Science ®Google Scholar
• Li J, Tripathi RC, Tripathi BJ. Drug-induced ocular disorders. Drug Saf 2008;31:127-41
   PubMed Web of Science ®Google Scholar
• Santaella RM, Fraunfelder FW. Ocular adverse effects associated with systemic medications: recognition and management. Drugs 2007;67:75-93
   PubMed Web of Science ®Google Scholar
• Novack GD. Ocular toxicology. Curr Opin Ophthalmol 1997;8:88-92
   PubMedGoogle Scholar
• Novack GD. Ocular toxicology. Curr Opin Ophthalmol 1995;6:108-12
   PubMedGoogle Scholar
• Kirk N, Gelatti KN, Gilger BC, et al. editors. Veterinary ophthalmology: two volumes. 5th Edition. Wiley-Blackwell. John Wiley & Sons, Inc, Ames, IA, USA; 2013
   Google Scholar
• Thomas BB, Seiler MJ, Sadda SR, et al. Optokinetic test to evaluate visual acuity of each eye independently. J Neurosci Methods 2004;138:7-13
   PubMed Web of Science ®Google Scholar
• Kinoshita J, Iwata N, Shimoda H, et al. Sildenafil-induced reversible impairment of rod and cone phototransduction in monkeys. Invest Ophthalmol Vis Sci 2015;56:664-73
   PubMed Web of Science ®Google Scholar
• Nivison-Smith L, Zhu Y, et al. Sildenafil alters retinal function in mouse carriers of retinitis pigmentosa. Exp Eye Res 2014;128:43-56
   PubMed Web of Science ®Google Scholar
• Rasmussen AD, Truchot N, Pickersgill N, et al. The effects of taurine on vigabatrin, high light intensity and mydriasis induced retinal toxicity in the pigmented rat. Exp Toxicol Pathol 2015;67:13-20
   PubMed Web of Science ®Google Scholar
• Stewart AM, Braubach O, Spitsbergen J, et al. Zebrafish models for translational neuroscience research: from tank to bedside. Trends Neurosci 2014;37:264-78
   PubMed Web of Science ®Google Scholar
• Neelkantan N, Mikhaylova A, Stewart AM, et al. Perspectives on zebrafish models of hallucinogenic drugs and related psychotropic compounds. ACS Chem Neurosci 2013;4:1137-50
   PubMed Web of Science ®Google Scholar
• Kalueff AV, Stewart AM, Gerlai R. Zebrafish as an emerging model for studying complex brain disorders. Trends Pharmacol Sci 2014;35:63-75
   PubMed Web of Science ®Google Scholar
• Kalueff AV, Gebhardt M, Stewart AM, et al. Zebrafish Neuroscience Research Consortium. Towards a comprehensive catalog of zebrafish behavior 1.0 and beyond. Zebrafish 2013;10:70-86
   PubMed Web of Science ®Google Scholar
• Kalueff AV, Echevarria DJ, Stewart AM. Gaining translational momentum: more zebrafish models for neuroscience research. Prog Neuropsychopharmacol Biol Psychiatry 2014;55:1-6
   PubMed Web of Science ®Google Scholar
• Horn CC. Measuring the nausea-to-emesis continuum in non-human animals: refocusing on gastrointestinal vagal signaling. Exp Brain Res 2014;232:2471-81
   PubMed Web of Science ®Google Scholar
• Holmes AM, Rudd JA, Tattersall FD, et al. Opportunities for the replacement of animals in the study of nausea and vomiting. Br J Pharmacol 2009;157:865-80
   PubMed Web of Science ®Google Scholar
• Sanger GJ, Holbrook JD, Andrews PL. The translational value of rodent gastrointestinal functions: a cautionary tale. Trends Pharmacol Sci 2011;32:402-9
   PubMed Web of Science ®Google Scholar
• Horn CC, Kimball BA, Wang H, et al. Why can’t rodents vomit? A comparative behavioral, anatomical, and physiological study. PLoS One 2013;8:e60537
   PubMed Web of Science ®Google Scholar
• Andrews PL, Horn CC. Signals for nausea and emesis: implications for models of upper gastrointestinal diseases. Auton Neurosci 2006;125:100-15
   PubMed Web of Science ®Google Scholar
• Smith JE, Friedman MI, Andrews PL. Conditioned food aversion in Suncus murinus (house musk shrew) -a new model for the study of nausea in a species with an emetic reflex. Physiol Behav 2001;73:593-8
   PubMed Web of Science ®Google Scholar
• Smith JE, Paton JF, Andrews PL. An arterially perfused decerebrate preparation of Suncus murinus (house musk shrew) for the study of emesis and swallowing. Exp Physiol 2002;87:563-74
   Google Scholar
• Percie du Sert N, Holmes AM, Wallis R, et al. Predicting the emetic liability of novel chemical entities: a comparative study. Br J Pharmacol 2012;165:1848-67
   PubMed Web of Science ®Google Scholar
• CSRC-HESI-SPS-FDA Meeting. (December 11, 2014a). CIPA Update Workshop. Available from: www.cardiac-safety.org.php53-3.ord1-1.websitetestlink.com/?page_id=1177&preview=true [Accessed 16 March 2014]
   Google Scholar
• Cavero I, Holzegrefe H. Comprehensive in vitro Proarrhythmia Assay, a novel in vitro/in silico paradigm to detect ventricular proarrhythmic liability: a visionary 21st century initiative. Expert Opin Drug Saf 2014;13:745-58
   PubMed Web of Science ®Google Scholar
• Sager PT, Gintant G, Turner JR, et al. Rechanneling the cardiac proarrhythmia safety paradigm: a meeting report from the Cardiac Safety Research Consortium. Am Heart J 2014;167:292-300
   PubMed Web of Science ®Google Scholar
• ICH Harmonised Tripartite Guideline. The non-clinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals. S7B. May 2005. Available from: www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Safety/S7B/Step4/S7B_Guideline.pdf [Accessed 16 March 2014]
   Google Scholar
• ICH Harmonised Tripartite Guideline. The clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs. E14. May 2005. Available from: www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E14/E14_Guideline.pdf [Accessed 16 March 2014]
   Google Scholar
• Ewart L, Aylott M, Deurinck M, et al. The Concordance between nonclinical and Phase I clinical cardiovascular assessment from a cross-company data sharing initiative. Toxicol Sci 2014;142:427-35
   PubMed Web of Science ®Google Scholar
• Kannel WB. Elevated systolic blood pressure as a cardiovascular risk factor. Am J Cardiol 2000;85:251-5
   PubMed Web of Science ®Google Scholar
• Asia Pacific Cohort Studies Collaboration. Kengne AP, Patel A, Barzi F, et al. Blood pressure, diabetes and the risk of cardiovascular diseases in the Asia-Pacific region. J Hypertens 2007;25:1205-13
   PubMed Web of Science ®Google Scholar
• ICH Harmonised Tripartite Guideline: Nonclinical evaluation for anticancer pharmaceuticals S9. October 2009. Available from: www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Safety/S9/Step4/S9_Step4_Guideline.pdf [Accessed 16 March 2014]
   Google Scholar
• ICH Harmonised Tripartite Guideline: safety pharmacology studies for human pharmaceuticals S7A. November 2000. Available from: www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Safety/S7A/Step4/S7A_Guideline.pdf [Accessed 16 March 2014]
   Google Scholar
• Truong J, Yan AT, Cramarossa G, et al. Chemotherapy-induced cardiotoxicity: detection, prevention, and management. Can J Cardiol 2014;30:869-78
   PubMed Web of Science ®Google Scholar
• Miltenburg NC, Boogerd W. Chemotherapy-induced neuropathy: a comprehensive survey. Cancer Treat Rev 2014;40:872-82
   PubMed Web of Science ®Google Scholar